Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer.

  • Authors : Yang J; Department of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu Province, 214023, China.; Tian Z

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/genetics ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/genetics

  • Source: BMC cancer [BMC Cancer] 2022 May 27; Vol. 22 (1), pp. 584. Date of Electronic Publication: 2022 May 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

×
Academic Journal

Determining the optimal PD-1/PD-L1 inhibitors for the first-line treatment of non-small-cell lung cancer with high-level PD-L1 expression in China.

  • Authors : Teng MM; Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Chen SY

Subjects: B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*analysis ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy ; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use

  • Source: Cancer medicine [Cancer Med] 2021 Sep; Vol. 10 (18), pp. 6344-6353. Date of Electronic Publication: 2021 Aug 12.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Automated tumor proportion score analysis for PD-L1 (22C3) expression in lung squamous cell carcinoma.

  • Authors : Liu J; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.; Histo Pathology Diagnostic Center, Shanghai, China.

Subjects: B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*genetics ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*diagnosis ; Gene Expression Profiling/Gene Expression Profiling/Gene Expression Profiling/*methods

  • Source: Scientific reports [Sci Rep] 2021 Aug 05; Vol. 11 (1), pp. 15907. Date of Electronic Publication: 2021 Aug 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

The association of genomic alterations with PD-L1 expression in Chinese patients with EGFR/ALK wild-type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy.

  • Authors : Liu F; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Zhang X

Subjects: Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/genetics ; Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/therapy

  • Source: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e7038.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Assessing the genomic feature of Chinese patients with ampullary adenocarcinoma: potential therapeutic targets.

  • Authors : Dong Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China.; Chong W

Subjects: Duodenal Neoplasms* ; Pancreatic Neoplasms* ; Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/drug therapy

  • Source: BMC cancer [BMC Cancer] 2024 Mar 04; Vol. 24 (1), pp. 286. Date of Electronic Publication: 2024 Mar 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

×
Academic Journal

Cost-effectiveness analysis of pembrolizumab plus chemotherapy with PD-L1 test for the first-line treatment of NSCLC.

  • Authors : Wan N; Department of Pharmacy, General Hospital of Southern Theater Command, Guangzhou, Guangdong, China.; Guangzhou Huabo Biopharmaceutical Research Institute, Guangzhou, Guangdong, China.

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*analysis

  • Source: Cancer medicine [Cancer Med] 2020 Mar; Vol. 9 (5), pp. 1683-1693. Date of Electronic Publication: 2020 Jan 16.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Genome-Wide Profiling of Human Papillomavirus DNA Integration into Human Genome and Its Influence on PD-L1 Expression in Chinese Uygur Cervical Cancer Women.

  • Authors : Yang-Chun F; Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, China.; Sen-Yu W

Subjects: B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*metabolism ; Genome, Human/Genome, Human/Genome, Human/*genetics ; Papillomaviridae/Papillomaviridae/Papillomaviridae/*isolation & purification

  • Source: Journal of immunology research [J Immunol Res] 2020 Jan 23; Vol. 2020, pp. 6284960. Date of Electronic Publication: 2020 Jan 23 (Print Publication: 2020).Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101627166 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Correlation between the Expression of PD-L1 and Clinicopathological Features in Patients with Thymic Epithelial Tumors.

  • Authors : Chen Y; Department of Pathology, Wenzhou People's Hospital, Wenzhou, Zhejiang 325000, China.; Zhang Y

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/analysis ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/genetics ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism Thymic epithelial tumor

  • Source: BioMed research international [Biomed Res Int] 2018 Apr 23; Vol. 2018, pp. 5830547. Date of Electronic Publication: 2018 Apr 23 (Print Publication: 2018).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Efficacy and safety of anlotinib combined with PD-1/PD-L1 inhibitors as second-line and subsequent therapy in advanced small-cell lung cancer.

  • Authors : Yu L; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.; Xu J

Subjects: Lung Neoplasms* ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/therapeutic use

  • Source: Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (5), pp. 5372-5383. Date of Electronic Publication: 2022 Oct 17.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

×
Report

The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials.

  • Authors : Wu D; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Huang H

Subjects: Neoadjuvant Therapy* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; B7-H1 Antigen

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2022 Feb 08; Vol. 15 (1), pp. 16. Date of Electronic Publication: 2022 Feb 08.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

×
  • 1-10 ل  18 نتائج ل ""B7-H1 Antigen""